Applied Materials stock slides 5.6% into February as chip-tool shares crack — what AMAT traders watch next

Applied Materials stock slides 5.6% into February as chip-tool shares crack — what AMAT traders watch next

New York, Feb 1, 2026, 14:43 EST — The market has closed.

  • Applied Materials dropped 5.6% on Friday amid a wider selloff in semiconductor stocks.
  • Shares of chipmaking equipment firms fell as well, leaving traders on edge ahead of Monday’s open.
  • Attention shifts to Applied’s earnings report on Feb. 12 for clues on 2026 tool demand and how much China weighs in.

Shares of Applied Materials, Inc. (AMAT) dropped 5.6% to close at $322.32 on Friday, wrapping up a tough week for chip-equipment stocks as selling pressure intensified late January.

This shift is crucial now, since the stock directly reflects confidence in chipmakers continuing to fund new factories and equipment. Investors are zeroing in on “wafer fab equipment,” or WFE — the gear used to produce chips — searching for clues that spending will ramp up again in 2026.

Friday’s sell-off came amid a jittery session after President Donald Trump tapped former Fed governor Kevin Warsh as his pick for Fed chair and a producer-price report came in hotter than anticipated. “You’ve got uncertainty… a new nominated chair,” noted Terry Sandven, chief equity strategist at U.S. Bank Asset Management. (Reuters)

Semiconductor ETFs were hit hard. The iShares Semiconductor ETF plunged 4.1%, with the VanEck Semiconductor ETF down 3.4% on Friday. Meanwhile, the SPDR S&P 500 ETF edged lower by 0.4%.

Chip tools took a harder hit. KLA Corp dropped 15.2%, Lam Research lost 5.9%, and Dutch lithography giant ASML slipped 2.2%.

KLA topped Wall Street forecasts late Thursday, boosted by strong demand for tools used in advanced chip production. Yet its shares slipped in after-hours trading. Michael Ashley Schulman, CIO at Running Point Capital Advisors, noted the stock had “sprinted into the print,” suggesting limited upside potential. (Reuters)

Earlier this week, Lam took a more upbeat stance, predicting quarterly revenue would exceed estimates thanks to strong demand for chipmaking tools. CEO Tim Archer highlighted the company’s “expanding product and services portfolio” as key to supporting the industry’s move toward smaller, more intricate devices. (Reuters)

For Applied, the focus now shifts away from just one quarter to the broader order tone: memory spending, demand for cutting-edge logic, and if service revenue can offset any slowdown in new tool shipments. Traders will be watching closely for clues about lead times and what customers have planned for their near-term budgets.

Still, the risk remains. Applied Materials warned in November that tougher U.S. export rules would curb its access to the China market and predicted chipmaking equipment spending there would drop in 2026. (Reuters)

Applied’s latest SEC proxy filing reveals it will hold its 2026 annual meeting on March 12 in Santa Clara, California. (SEC)

Applied is gearing up to release its fiscal first-quarter 2026 earnings, with a conference call scheduled for Feb. 12 at 4:30 p.m. ET. (Nasdaq)

U.S. trading picks up Monday, with investors zeroing in on the chip-equipment sector to steady itself after Friday’s drop. AMAT faces its next major hurdle on Feb. 12.

Stock Market Today

  • John McEnroe Reacts to Novak Djokovic's Australian Open Speech and Future Speculations
    February 1, 2026, 3:04 PM EST. After Novak Djokovic's tense Australian Open final loss to Carlos Alcaraz, tennis legend John McEnroe praised Djokovic's gracious post-match speech, calling it a 'class act.' Djokovic, who led early but ultimately fell, hinted uncertainty about his future, saying, 'God knows what happens tomorrow.' McEnroe acknowledged the tennis star's unresolved plans for next year, fueling retirement speculation. Djokovic attributed his loss to declining physicality, yet his strong performance and resilience highlighted he remains competitive at 38. Analysts suggest Djokovic's near 25th Grand Slam pursuit and victories over top players signal he is still capable of elite play despite questions around the end of his career.
UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move
Previous Story

UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

Go toTop